Phatak, P., Brissot, P., Wurster, M., Adams, P., Bonkovsky, H., Gross, J., et al. (2010). A Phase I/Ii, Open-Label, Dose-Escalation Trial Using The Once-Daily Oral Chelator Deferasirox To Treat Iron Overload In Hfe-Related Hereditary Hemochromatosis: Final Results. Intervento presentato a: Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna [10.1016/S0168-8278(10)60189-4].

A Phase I/Ii, Open-Label, Dose-Escalation Trial Using The Once-Daily Oral Chelator Deferasirox To Treat Iron Overload In Hfe-Related Hereditary Hemochromatosis: Final Results

PIPERNO, ALBERTO;
2010

abstract
Dose-Escalation Trial, Oral Chelator Deferasirox, Hfe-Related Hereditary Hemochromatosis, Iron Overload
English
Annual Meeting of the European-Association-for-the-Study-of-the-Liver
2010
2010
52
supplement 1
S81
S81
none
Phatak, P., Brissot, P., Wurster, M., Adams, P., Bonkovsky, H., Gross, J., et al. (2010). A Phase I/Ii, Open-Label, Dose-Escalation Trial Using The Once-Daily Oral Chelator Deferasirox To Treat Iron Overload In Hfe-Related Hereditary Hemochromatosis: Final Results. Intervento presentato a: Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna [10.1016/S0168-8278(10)60189-4].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/77166
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
Social impact